Zaloguj się

Gotowe bibliografie tematyczne / Neurofibromatosis 1 And 2 / Artykuły w czasopismach

Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Neurofibromatosis 1 And 2.

Artykuły w czasopismach na temat „Neurofibromatosis 1 And 2”

Autor: Grafiati

Data publikacji: 2 czerwca 2025

Data aktualizacji: 31 lipca 2025

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Neurofibromatosis 1 And 2”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.

1

Batista, Pollyanna Barros, Eny Maria Goloni Bertollo, Danielle de Souza Costa, et al. "Neurofibromatosis: part 2 – clinical management." Arquivos de Neuro-Psiquiatria 73, no. 6 (2015): 531–43. http://dx.doi.org/10.1590/0004-282x20150042.

Pełny tekst źródła

Streszczenie:

Part 1 of this guideline addressed the differential diagnosis of the neurofibromatoses (NF): neurofibromatosis type 1 (NF1), neurofibromatosis type 2 (NF2) and schwannomatosis (SCH). NF shares some features such as the genetic origin of the neural tumors and cutaneous manifestations, and affects nearly 80 thousand Brazilians. Increasing scientific knowledge on NF has allowed better clinical management and reduced rate of complications and morbidity, resulting in higher quality of life for NF patients. Most medical doctors are able to perform NF diagnosis, but the wide range of clinical manifes

Style APA, Harvard, Vancouver, ISO itp.

2

Rodrigues, Luiz Oswaldo Carneiro, Pollyanna Barros Batista, Eny Maria Goloni-Bertollo, et al. "Neurofibromatoses: part 1 ? diagnosis and differential diagnosis." Arquivos de Neuro-Psiquiatria 72, no. 3 (2014): 241–50. http://dx.doi.org/10.1590/0004-282x20130241.

Pełny tekst źródła

Streszczenie:

Neurofibromatoses (NF) are a group of genetic multiple tumor growing predisposition diseases: neurofibromatosis type 1 (NF1), neurofibromatosis type 2 (NF2) and schwannomatosis (SCH), which have in common the neural origin of tumors and cutaneous signs. They affect nearly 80 thousand of Brazilians. In recent years, the increased scientific knowledge on NF has allowed better clinical management and reduced complication morbidity, resulting in higher quality of life for NF patients. In most cases, neurology, psychiatry, dermatology, clinical geneticists, oncology and internal medicine specialist

Style APA, Harvard, Vancouver, ISO itp.

3

Mulvihill, John J. "Neurofibromatosis 1 (Recklinghausen Disease) and Neurofibromatosis 2 (Bilateral Acoustic Neurofibromatosis)." Annals of Internal Medicine 113, no. 1 (1990): 39. http://dx.doi.org/10.7326/0003-4819-113-1-39.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

4

Pollack, Ian F., and Jonn J. Mulvihill. "Neurofibromatosis 1 and 2." Brain Pathology 7, no. 2 (1997): 823–36. http://dx.doi.org/10.1111/j.1750-3639.1997.tb01067.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

5

Sanchez, Lauren D., Ashley Bui, and Laura J. Klesse. "Targeted Therapies for the Neurofibromatoses." Cancers 13, no. 23 (2021): 6032. http://dx.doi.org/10.3390/cancers13236032.

Pełny tekst źródła

Streszczenie:

Over the past several years, management of the tumors associated with the neurofibromatoses has been recognized to often require approaches that are distinct from their spontaneous counterparts. Focus has shifted to therapy aimed at minimizing symptoms given the risks of persistent, multiple tumors and new tumor growth. In this review, we will highlight the translation of preclinical data to therapeutic trials for patients with neurofibromatosis, particularly neurofibromatosis type 1 and neurofibromatosis type 2. Successful inhibition of MEK for patients with neurofibromatosis type 1 and progr

Style APA, Harvard, Vancouver, ISO itp.

6

Reynolds, RM, GGP Browning, I. Nawroz, and IW Campbell. "Von Recklinghausen's neurofibromatosis: neurofibromatosis type 1." Lancet 361, no. 9368 (2003): 1552–54. http://dx.doi.org/10.1016/s0140-6736(03)13166-2.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

7

Yehouenou Tessi, Romeo Thierry, Chaimae Lahlou, Soufiane Rostoum, Siham El Haddad, Nazik Allali, and Latifa Chat. "A supraclavicular mass with skin macules «café-au-lait»: Neurofibromatosis 1." International Journal of Case Reports and Images 14, no. 2 (2023): 57–62. http://dx.doi.org/10.5348/101411z01rt2023cr.

Pełny tekst źródła

Streszczenie:

Neurofibromatosis type 1 is a genetic disorder representing one of the most common forms of Von Recklinghausen’s disease. The neurofibromatoses are a group of heterogeneous, yet distinct, autosomal-dominant inherited neurogenetic disorders that include neurofibromatosis type 1 (NF1), neurofibromatosis type 2 (NF2), and schwannomatosis. It is characterized by a large clinical polymorphism with the development of «café-au-lait» skin spots, benign tumors affecting the skin, peripheral nerves, optic pathway, and can involve the brain, bones, and vessels. We report the case of an 8-year-old child w

Style APA, Harvard, Vancouver, ISO itp.

8

Flexon, Phillip B., Joseph B. Nadol, William W. Montgomery, Harold F. Schuknecht, and Robert L. Martuza. "Bilateral Acoustic Neurofibromatosis (Neurofibromatosis 2): A Disorder Distinct from Von Recklinghausen's Neurofibromatosis (Neurofibromatosis 1)." Annals of Otology, Rhinology & Laryngology 100, no. 10 (1991): 830–34. http://dx.doi.org/10.1177/000348949110001008.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

9

Borofsky, S., and L. M. Levy. "Neurofibromatosis: Types 1 and 2." American Journal of Neuroradiology 34, no. 12 (2013): 2250–51. http://dx.doi.org/10.3174/ajnr.a3534.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

10

Yohay, Kaleb. "Neurofibromatosis Types 1 and 2." Neurologist 12, no. 2 (2006): 86–93. http://dx.doi.org/10.1097/01.nrl.0000195830.22432.a5.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

11

North, Kathryn. "Neurofibromatosis Type 1." American Journal of Medical Genetics 97, no. 2 (2000): 119–27. http://dx.doi.org/10.1002/1096-8628(200022)97:2<119::aid-ajmg3>3.0.co;2-3.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

12

Ferner, Rosalie E. "Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective." Lancet Neurology 6, no. 4 (2007): 340–51. http://dx.doi.org/10.1016/s1474-4422(07)70075-3.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

13

Viskochil, Dave. "Neurofibromatosis 1." American Journal of Medical Genetics 89, no. 1 (1999): v—viii. http://dx.doi.org/10.1002/(sici)1096-8628(19990326)89:13.0.co;2-i.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

14

Halliday, Andrea L., Raymond A. Sobel, and Robert L. Martuza. "Benign spinal nerve sheath tumors: their occurrence sporadically and in neurofibromatosis types 1 and 2." Journal of Neurosurgery 74, no. 2 (1991): 248–53. http://dx.doi.org/10.3171/jns.1991.74.2.0248.

Pełny tekst źródła

Streszczenie:

✓ Benign spinal nerve sheath tumors (neurofibromas and schwannomas) often occur on dorsal nerve roots sporadically or in neurofibromatosis types 1 and 2. These are histologically benign tumors, and distinction between them is frequently not made by clinicians. To determine if there is a correlation between the histological pattern of benign spinal nerve sheath tumors and the type of neurofibromatosis, the clinical and pathological features of these tumors (86 surgical specimens and five autopsies) in 68 patients were reviewed. The patients were classified into one of four categories: neurofibr

Style APA, Harvard, Vancouver, ISO itp.

15

Leśniewski, Michał, Iwona Welian-Polus, Izabela Oleksak, and Karolina Maliszewska. "Diagnostic and therapeutic process of neurofibromatosis type 1 and type 2." Journal of Education, Health and Sport 63 (February 24, 2024): 168–81. http://dx.doi.org/10.12775/jehs.2024.63.013.

Pełny tekst źródła

Streszczenie:

Neurofibromatosis is one of the most common genetic diseases. It is inherited in an autosomal dominant manner. It is divided into two genetically distinct subtypes, characterised by multiple skin lesions and tumours of the peripheral and central nervous system. Neurofibromatosis type 1, or Recklinghausen's disease, is the most common phakomatosis. The disease is genetically determined by a mutation of the neurofibromin- 1 gene on chromosome 17. Neurofibromatosis type 2 accounts for 3% of all cases. The disease is genetically determined - caused by a mutation of the neurofibromin-2 gene on chro

Style APA, Harvard, Vancouver, ISO itp.

16

Ardern-Holmes, Simone, Gemma Fisher, and Kathryn North. "Neurofibromatosis Type 2." Journal of Child Neurology 32, no. 1 (2016): 9–22. http://dx.doi.org/10.1177/0883073816666736.

Pełny tekst źródła

Streszczenie:

Neurofibromatosis type 2 (NF2) is a rare autosomal dominant disorder (incidence 1:33 000-40 000) characterized by formation of central nervous system tumors, due to mutation in the NF2 gene on chromosome 22q12. Vestibular schwannomas are the hallmark lesion, affecting 95% of individuals and typically occur bilaterally. Schwannomas commonly occur on other nerves intracranially and in the spinal compartment, along with meningiomas, ependymomas, and gliomas. Although histologically benign, tumors are associated with significant morbidity due to multiple problems including hearing and vision loss,

Style APA, Harvard, Vancouver, ISO itp.

17

Gutmann, David H., and Marco Giovannini. "Mouse Models of Neurofibromatosis 1 and 2." Neoplasia 4, no. 4 (2002): 279–90. http://dx.doi.org/10.1038/sj.neo.7900249.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

18

Constant, Errikos. "The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2." Plastic & Reconstructive Surgery 102, no. 5 (1998): 1796. http://dx.doi.org/10.1097/00006534-199810000-00135.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

19

Aylsworth, A., JC Carey, B. Korf, et al. "The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2." American Journal of Ophthalmology 124, no. 5 (1997): 718–19. http://dx.doi.org/10.1016/s0002-9394(14)70930-4.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

20

Gutmann, David H. "The Diagnostic Evaluation and Multidisciplinary Management of Neurofibromatosis 1 and Neurofibromatosis 2." JAMA: The Journal of the American Medical Association 278, no. 1 (1997): 51. http://dx.doi.org/10.1001/jama.1997.03550010065042.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

21

Gutmann, D. H. "The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2." JAMA: The Journal of the American Medical Association 278, no. 1 (1997): 51–57. http://dx.doi.org/10.1001/jama.278.1.51.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

22

Mantoglu, Baris, Burak Kamburoglu, Ismail Zengin, et al. "Coexistence of Neurofibromatosis Type 1 and Male Breast Cancer." Archives of Iranian Medicine 24, no. 11 (2021): 852–55. http://dx.doi.org/10.34172/aim.2021.126.

Pełny tekst źródła

Streszczenie:

Breast cancer is one of the rarest types of cancer in men. Its incidence increases with age, as in women. Neurofibromatosis type 1 is an autosomal dominant genetic disease that predisposes to many cancer types. Neurofibromatosis and breast cancer have been more frequently distinguished and better studied in women. Characteristically, estrogen, progesterone receptors, negative, and overexpression of human epidermal growth factor receptor 2 (HER2) are detected in patients with female neurofibromatosis breast cancers. In cases reported so far, estrogen and progesterone receptors have been evaluat

Style APA, Harvard, Vancouver, ISO itp.

23

Alonso, G., D. Fernández-García, and P. Rozas-Moreno. "Neurofibromatosis tipo 1 y feocromocitoma." Hipertensión 22, no. 7 (2005): 302. http://dx.doi.org/10.1016/s0212-8241(05)71577-2.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

24

Büki, Gergely, Ágnes Till, Anna Zsigmond, Judit Bene, and Kinga Hadzsiev. "Neurofibromatosis-1 microdeletiós szindróma." Orvosi Hetilap 163, no. 51 (2022): 2041–51. http://dx.doi.org/10.1556/650.2022.32673.

Pełny tekst źródła

Streszczenie:

Az 1-es típusú neurofibromatosis autoszomális domináns öröklésmenetet mutató, klinikailag rendkívül heterogén neurocutan kórkép, amelynek kialakulásában elsődlegesen az NF1-gén intragenikus funkcióvesztéses mutációi játszanak szerepet. Ugyanakkor a molekuláris diagnosztika fejlődésének köszönhetően egyre több esetben sikerül kimutatni az NF1-gént és az azzal szomszédos régiókat érintő kópiaszámbeli variánsokat. Genotípus-fenotípus elemzések alapján a pontmutációs eltérések okozta 1-es típusú neurofibromatosis, illetve a microdeletiós eltérések okozta, ún. 17q11.2 microdeletiós szindróma elkülö

Style APA, Harvard, Vancouver, ISO itp.

25

Bhardwaj, Ashu, and Ajay Mahajan. "Gingival Enlargement in Neurofibromatosis Type 1: A Case Report and Literature Review." Journal of Contemporary Dental Practice 11, no. 2 (2010): 57–63. http://dx.doi.org/10.5005/jcdp-11-2-57.

Pełny tekst źródła

Streszczenie:

Abstract Aim The purpose of this article is to describe a rare case of neurofibromatosis1 (NF1) of the gingiva and a review of the current literature. Background Neurofibromatosis1 (NF1) of the gingiva is an uncommon cause of gingival enlargement. The disease is clinically characterized by epidermal melanosis, nevi, and flabby skin or bone malformations; in addition, the lesions may undergo malignant transformation. Involvement of the gingiva with or without concurrent skin lesions has been reported only occasionally. Case Description A 40-year-old male patient with a history of NF1 came to us

Style APA, Harvard, Vancouver, ISO itp.

26

Ardizzone, Alessio, Anna Paola Capra, Michela Campolo, Alessia Filippone, Emanuela Esposito, and Silvana Briuglia. "Neurofibromatosis: New Clinical Challenges in the Era of COVID-19." Biomedicines 10, no. 5 (2022): 940. http://dx.doi.org/10.3390/biomedicines10050940.

Pełny tekst źródła

Streszczenie:

Rare diseases constitute a wide range of disorders thus defined for their low prevalence. However, taken together, rare diseases impact a considerable percentage of the world population, thus representing a public healthcare problem. In particular, neurofibromatoses are autosomal-dominant genetic disorders that include type 1 neurofibromatosis (NF1), type 2 neurofibromatosis (NF2) and schwannomatosis. Each of the three types is a genetically distinct disease with an unpredictable clinical course and for which there is still no resolutive cure. Therefore, a personalized therapeutic approach dir

Style APA, Harvard, Vancouver, ISO itp.

27

Shaida, A. M., D. G. O’Donovan, and D. A. Moffat. "Schwannomatosis in a child – or early neurofibromatosis type 2." Journal of Laryngology & Otology 116, no. 7 (2002): 551–55. http://dx.doi.org/10.1258/002221502760132692.

Pełny tekst źródła

Streszczenie:

A case of multiple cervical schwannomas in a five-year-old boy, without other evidence of neurofibromatosis type 2, is described. Schwannomatosis is a disorder characterized by the presence of multiple schwannomas in the absence of neurofibromatosis type 2 that has only been recognized in the last 15 years. The clinical and genetic features of neurofibromatosis types 1 and 2 and schwannomatosis are compared and contrasted. This patient with possible schwannomatosis is presented to illustrate the potential pitfalls of making this diagnosis in the paediatric age group and to increase awareness o

Style APA, Harvard, Vancouver, ISO itp.

28

Yang, Chao-Chun, Rudolf Happle, Sheau-Chiou Chao, Julia Yu-Yun Lee, and WenChieh Chen. "Giant café-au-lait macule in neurofibromatosis 1: A type 2 segmental manifestation of neurofibromatosis 1?" Journal of the American Academy of Dermatology 58, no. 3 (2008): 493–97. http://dx.doi.org/10.1016/j.jaad.2007.03.013.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

29

Neary, W. J., V. E. Newton, M. Vidler, et al. "A clinical, genetic and audiological study of patients and families with bilateral acoustic neurofibromatosis." Journal of Laryngology & Otology 107, no. 1 (1993): 6–11. http://dx.doi.org/10.1017/s0022215100121991.

Pełny tekst źródła

Streszczenie:

AbstractThe neurofibromatoses consist of at least two distinct autosomal dominant hereditary disorders. Neurofibromatosis type 1 (NF1) is due to a lesion on chromosome 17q. Neurofibromatosis type 2 (NF2) is caused by a defect on chromosome 22q. The hallmark of NF2 is the development, in the second and third decades, of bilateral acoustic neuromas. NF1 is characterized by the appearance of cafe-au-lait spots and neurofibromas in addition to iris hamartomas, or Lisch nodules, of the eye, during the first and second decades.Ten families were personally studied. A total of 16 members were found to

Style APA, Harvard, Vancouver, ISO itp.

30

Rodriguez, Diana, and Tina Young Poussaint. "Neuroimaging findings in neurofibromatosis type 1 and 2." Neuroimaging Clinics of North America 14, no. 2 (2004): 149–70. http://dx.doi.org/10.1016/j.nic.2004.03.004.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

31

Ruggieri, Martino, Andrea D. Praticò, Stefano Catanzaro, Stefano Palmucci, and Agata Polizzi. "Did Cro-Magnon 1 have neurofibromatosis type 2?" Lancet 392, no. 10148 (2018): 632–33. http://dx.doi.org/10.1016/s0140-6736(18)31544-7.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

32

Aoki, S., A. J. Barkovich, K. Nishimura, et al. "Neurofibromatosis types 1 and 2: cranial MR findings." Radiology 172, no. 2 (1989): 527–34. http://dx.doi.org/10.1148/radiology.172.2.2501822.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

33

Neary, W. J., V. E. Newton, S. N. Laoide-Kemp, et al. "A clinical, genetic and audiological study of patients and families with unilateral vestibular schwannomas. I. Clinical features of neurofibromatosis in patients with unilateral vestibular schwannomas." Journal of Laryngology & Otology 110, no. 7 (1996): 634–40. http://dx.doi.org/10.1017/s0022215100134486.

Pełny tekst źródła

Streszczenie:

AbstractNinety-three patients with unilateral vestibular schwannomas were examined in a clinical, genetic and audiological study, to determine whether they had features associated with neurofibromatosis Type 1 or neurofibromatosis Type 2. In 91 families, one patient only was found to be affected with a unilateral vestibular schwannoma. Patients did have a few café-au-lait macules, but fewer than six in number. None of the patients satisfied the cutaneous diagnostic criteria for neurofibromatosis Type 1. Neither Lisch nodules nor presenile posterior subcapsular lenticular opacities or cortical

Style APA, Harvard, Vancouver, ISO itp.

34

Kayl, Anne E., and Bartlett D. Moore. "Behavioral phenotype of neurofibromatosis, type 1." Mental Retardation and Developmental Disabilities Research Reviews 6, no. 2 (2000): 117–24. http://dx.doi.org/10.1002/1098-2779(2000)6:2<117::aid-mrdd5>3.0.co;2-x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

35

Raja, Ali I., Gabrielle A. Yeaney, Regina I. Jakacki, Ronald L. Hamilton, and Ian F. Pollack. "Extraventricular neurocytoma in neurofibromatosis Type 1." Journal of Neurosurgery: Pediatrics 2, no. 1 (2008): 63–67. http://dx.doi.org/10.3171/ped/2008/2/7/063.

Pełny tekst źródła

Streszczenie:

Neurocytomas are rare tumors of the central nervous system that are typically located in the ventricular system. The authors report a case of a child with neurofibromatosis Type 1 (NF1) who had a tumor of the optic nerves and chiasm with signal abnormality extending through the diencephalon, as well as an occipital lobe mass, which was presumed to be part of the visual pathway neoplasm. Because the occipital lobe lesion slowly increased in size over time, while the other areas remained stable, a biopsy was performed. Pathological evaluation revealed an extraventricular neurocytoma of extravent

Style APA, Harvard, Vancouver, ISO itp.

36

Baldwin, Robert L., and Kenneth LeMaster. "NEUROFIBROMATOSIS-2 AND BILATERAL ACOUSTIC NEUROMAS: DISTINCTIONS FROM NEUROFIBROMATOSIS-1 (VON RECKLINGHAUSEN??S DISEASE)." Otology & Neurotology 10, no. 6 (1989): 439–42. http://dx.doi.org/10.1097/00129492-198911000-00004.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

37

Fisher, Michael J., Allan J. Belzberg, Peter de Blank, et al. "2016 Children's Tumor Foundation conference on neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis." American Journal of Medical Genetics Part A 176, no. 5 (2018): 1258–69. http://dx.doi.org/10.1002/ajmg.a.38675.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

38

Ferner, Rosalie E., Annette Bakker, Ype Elgersma, et al. "From process to progress—2017 International Conference on Neurofibromatosis 1, Neurofibromatosis 2 and Schwannomatosis." American Journal of Medical Genetics Part A 179, no. 6 (2019): 1098–106. http://dx.doi.org/10.1002/ajmg.a.61112.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

39

Subbarao, Kakarla. "Neurofibromatosis – Imaging Spectrum." Nepalese Journal of Radiology 2, no. 2 (2013): 1–12. http://dx.doi.org/10.3126/njr.v2i2.7679.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

40

Diallo, Ibrahima Dokal, Zaynab Iraqi Houssaini, Mehdi Tantaoui, et al. "Bone Manifestations of Neurofibromatosis Type 1." Global Pediatric Health 9 (January 2022): 2333794X2211017. http://dx.doi.org/10.1177/2333794x221101771.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

41

Belakhoua, Sarra M., and Fausto J. Rodriguez. "Diagnostic Pathology of Tumors of Peripheral Nerve." Neurosurgery 88, no. 3 (2021): 443–56. http://dx.doi.org/10.1093/neuros/nyab021.

Pełny tekst źródła

Streszczenie:

Abstract Neoplasms of the peripheral nervous system represent a heterogenous group with a wide spectrum of morphological features and biological potential. They range from benign and curable by complete excision (schwannoma and soft tissue perineurioma) to benign but potentially aggressive at the local level (plexiform neurofibroma) to the highly malignant (malignant peripheral nerve sheath tumors [MPNST]). In this review, we discuss the diagnostic and pathologic features of common peripheral nerve sheath tumors, particularly those that may be encountered in the intracranial compartment or in

Style APA, Harvard, Vancouver, ISO itp.

42

Frawley, Kieran J., Ralph Cohen, Edward V. O'Loughlin, Kathryn North, and Susan Arbuckle. "Neurofibromatosis of the small intestine mesentery in a child with neurofibromatosis type 1." Journal of Pediatric Surgery 32, no. 12 (1997): 1783–85. http://dx.doi.org/10.1016/s0022-3468(97)90535-2.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

43

Millichap, J. Gordon. "CNS Tumors and Neurofibromatosis." Pediatric Neurology Briefs 3, no. 2 (1989): 9. http://dx.doi.org/10.15844/pedneurbriefs-3-2-1.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

44

Millichap, J. Gordon. "Neurofibromatosis 1, Thalamic Hyperintensities, and Cognitive Impairment." Pediatric Neurology Briefs 21, no. 10 (2007): 74. http://dx.doi.org/10.15844/pedneurbriefs-21-10-2.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

45

Mustafin, R. N. "Clinical Masks of Neurofibromatosis Type 1." Russian Archives of Internal Medicine 12, no. 2 (2022): 93–103. http://dx.doi.org/10.20514/2226-6704-2021-12-2-93-103.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

46

Friedman, J. M. "Epidemiology of neurofibromatosis type 1." American Journal of Medical Genetics 89, no. 1 (1999): 1–6. http://dx.doi.org/10.1002/(sici)1096-8628(19990326)89:1<1::aid-ajmg3>3.0.co;2-8.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

47

Clementi, M., S. Milani, I. Mammi, S. Boni, C. Monciotti, and R. Tenconi. "Neurofibromatosis type 1 growth charts." American Journal of Medical Genetics 87, no. 4 (1999): 317–23. http://dx.doi.org/10.1002/(sici)1096-8628(19991203)87:4<317::aid-ajmg7>3.0.co;2-x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

48

Dugoff, Lorraine, and Eva Sujansky. "Neurofibromatosis type 1 and pregnancy." American Journal of Medical Genetics 66, no. 1 (1996): 7–10. http://dx.doi.org/10.1002/(sici)1096-8628(19961202)66:1<7::aid-ajmg2>3.0.co;2-r.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

49

Takahashi, Kazuhiro, Hiroyuki Suzuki, Masahito Hatori, et al. "Reduced Expression of Neurofibromin in the Soft Tissue Tumours Obtained from Patients with Neurofibromatosis Type 1." Clinical Science 88, no. 5 (1995): 581–85. http://dx.doi.org/10.1042/cs0880581.

Pełny tekst źródła

Streszczenie:

1. We analysed the expression of neurofibromin mRNAs, encoded by the gene responsible for neurofibromatosis type 1, and of neurofibromin protein in nine soft tissue tumours by S1 nuclease mapping and Western blot analyses. Four tumours were obtained from patients with neurofibromatosis type 1, comprising two neurofibromas, one fibrolipoma and one malignant schwannoma, and five neurogenic tumours were obtained from non-neurofibromatosis type 1 patients. 2. All tumours, except for a malignant schwannoma, similarly expressed three species of mRNA encoding neurofibromin, an isoform with the insert

Style APA, Harvard, Vancouver, ISO itp.

50

Tamura, Ryota. "Current Understanding of Neurofibromatosis Type 1, 2, and Schwannomatosis." International Journal of Molecular Sciences 22, no. 11 (2021): 5850. http://dx.doi.org/10.3390/ijms22115850.

Pełny tekst źródła

Streszczenie:

Neurofibromatosis (NF) is a neurocutaneous syndrome characterized by the development of tumors of the central or peripheral nervous system including the brain, spinal cord, organs, skin, and bones. There are three types of NF: NF1 accounting for 96% of all cases, NF2 in 3%, and schwannomatosis (SWN) in <1%. The NF1 gene is located on chromosome 17q11.2, which encodes for a tumor suppressor protein, neurofibromin, that functions as a negative regulator of Ras/MAPK and PI3K/mTOR signaling pathways. The NF2 gene is identified on chromosome 22q12, which encodes for merlin, a tumor suppressor pr

Style APA, Harvard, Vancouver, ISO itp.

Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!